Atorvastatin/aspirin/ramiprilAlternative Names: Aspirin/ramipril/atorvastatin; Atorvastatin/acetylsalicylic acid/ramipril; Atorvastatin/ASA/ramipril; Ramipril/atorvastatin/aspirin
Latest Information Update: 10 Jun 2016
At a glance
- Originator Ferrer
- Class Heterocyclic bicyclo compounds; Naphthalenes; Nonsteroidal anti-inflammatories; Salicylates; Small molecules
- Mechanism of Action ACE inhibitors; Cyclooxygenase inhibitors; HMG-CoA reductase inhibitors; Nitric oxide stimulants; Platelet aggregation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Myocardial infarction
- Phase II Hypertension
Most Recent Events
- 11 Mar 2016 Phase-III SECURE trial in Myocardial infarction in Czech Republic (PO) (EudraCT2015-002868-17)